Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacokinetics, and Preliminary Efficacy of FS-8002
Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacokinetics, and Preliminary Efficacy of FS-8002
Recruiting · NCT06832982 · Registry updated 2026-08-04Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacokinetics, and Preliminary Efficacy of FS-8002 | Advanced Solid Tumors | Recruiting | Phase 1 | 2026-08-04 | NCT06832982 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Shanghai Pushi Medical Science Co. Ltd | 1 |
10 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Beijing Cancer Hospital | Beijing | China | 208 |
| Cancer Hospital of Shandong First Medical University(Shandong Cancer Institute,Shandong Cancer Hospital) | Shandong | China | 1 |
| Fujian Cancer hospital | Fujian | China | 1 |
| Harbin Medical University Cancer Hospital | Heilongjiang | China | 2 |
| Hebei General Hospital | Hebei | China | 1 |
| Hubei Cancer Hospital | Hubei | China | 1 |
| Meizhou People's Hospital | Guangdong | China | 1 |
| The First Affiliated Hospital of China Medical University | Shenyang | China | 1 |
| The First Affiliated Hospital of Zhejiang Medical University | Zhejiang | China | 1 |
| Union Hospital, Tongji Medical College | Hubei | China | 1 |